Antiretroviral Therapy (Track:- Fundamentals of HIV for Primary Care Providers)
Salon 4
Javier Marinez, MD

The speaker will briefly review the natural history of HIV and the different target sites for drug therapy before discussing the current DHHS guidelines. A brief review of the pharmacology of the different antiretrovirals will be presented including the pros and cons of each agent. Consideration of the patient's baseline co morbidities will also be discussed.

ARVs: What We Have and What is Coming (Track:- Nursing Issues in HIV Care)
Signature 1
Michael Thompson, PharmD, BCNSP

This session will present the different classes of antiretroviral medications that are available for HIV-infected patients.  Information on the different ARVs will include potency, formulation, half life and side effects. Drug-to-drug interactions and what to avoid will also be discussed.

Antiretroviral Adverse Effects (Track:- Fundamentals of HIV for Primary Care Providers)
Salon 4
Luis A. Espinoza, MD
The use of antiretrovirals in the treatment of HIV infection has brought a whole new set of toxicities which were initially not recognized as a complication of this therapy. As patients have been living longer we are encountering complications from the long-term use of those medications and the chronic nature of the disease. Different manifestations include: Body-fat abnormalities, Dyslipidemia, hyperglycemia (with or without diabetes), osteoporosis and osteonecrosis, and immune reconstitution inflammatory syndrome.

Recognition of drug interactions is especially important in the care of HIV infected patients. Many patients are on a number of medications for chronic conditions such as hyperlipidemia, depression, seizure disorders, or chronic pain. Additionally, many patients require polypharmacy for the treatment of HIV, concurrent opportunistic infections or disease-related complications. This lecture will discuss the most frequently encountered drug interactions for HIV care providers and discuss tools for the recognition and management of these.

Resistance Testing (Track:- Fundamentals of HIV for Primary Care Providers)
Salon 4
Joanne J. Orrick, PharmD, BCPS

This presentation will provide a basic overview of resistance testing for the practitioner who is just starting out in the treatment of HIV-infected patients or those wanting a refresher on the fundamentals of resistance testing. The following topics will be reviewed in this presentation: guidelines for the use of resistance testing, overview of available resistance tests, review of most common resistance mutations, and resources for resistance testing interpretation.

Emerging Therapies (Track:- Specialty Care for Advanced HIV Clinicians)
Salon 3
Michael Kolber, PhD, MD

This session will present emerging efforts to boost host immunity to HIV, and areas for development of pharmacologic interventions. These include strategies for improving outcomes as well as new technology. Vaccine efforts and cytokine interventions will be discussed. Aptamer therapy and a potential role in HIV therapeutic intervention will be explored.

Antiretroviral Therapy in Adolescents (Track:- Pediatric/Adolescent HIV Care)
Signature 2
Kimberley Brown, PharmD

This session will open with a quick review of the basic principles of antiretroviral therapy. A discussion of utilizing genotype and phenotype information and salvage protocols will be presented. Case examples will be used for illustration and discussion.